Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARIANNE J PINKSTON

Allopathic & Osteopathic Physicians Family Medicine

NPI
1699756387
CMS profile
348946
Location
SAN ANTONIO, TX

General Payments · PY2018–2024

$6,067.37

  • Reported across 230 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$263.71

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $263.71 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $64.43 3
Otsuka America Pharmaceutical, Inc. $44.01 2
PFIZER INC. $42.74 2
ALK-Abello, Inc $39.67 2
ITI, Inc. $31.66 2
Lilly USA, LLC $22.89 1
Bayer HealthCare Pharmaceuticals Inc. $18.31 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $205.82 15
PY2019 $591.51 20
PY2020 $1,597.22 55
PY2021 $1,708.76 53
PY2022 $788.78 41
PY2023 $911.57 33
PY2024 $263.71 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $23.68 01/25/2024 Food and Beverage Undisputed 01/23/2026 1105272150 CMS
ABBVIE INC. $21.28 02/05/2024 Food and Beverage Undisputed 01/23/2026 1105272154 CMS
ABBVIE INC. $19.47 07/01/2024 Food and Beverage Undisputed 01/23/2026 1105272158 CMS
ALK-Abello, Inc $21.98 08/06/2024 Food and Beverage Undisputed 01/23/2026 1099894259 CMS
ALK-Abello, Inc $17.69 09/03/2024 Food and Beverage Undisputed 01/23/2026 1099894257 CMS
Bayer Healthcare Pharmaceuticals Inc. $18.31 04/01/2024 Food and Beverage Undisputed 01/23/2026 1086143403 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.67 06/07/2024 Food and Beverage Undisputed 01/23/2026 1143296606 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $14.99 12/11/2024 Food and Beverage Undisputed 01/23/2026 1143296609 CMS
Lilly USA, LLC $22.89 02/20/2024 Food and Beverage Undisputed 01/23/2026 1135160538 CMS
Otsuka America Pharmaceutical, Inc. $22.80 02/26/2024 Food and Beverage Undisputed 01/23/2026 1118961763 CMS
Otsuka America Pharmaceutical, Inc. $21.21 08/13/2024 Food and Beverage Undisputed 01/23/2026 1118961765 CMS
PFIZER INC. $24.13 07/10/2024 Food and Beverage Undisputed 01/23/2026 1132012180 CMS
PFIZER INC. $18.61 09/24/2024 Food and Beverage Undisputed 01/23/2026 1130887651 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.